Prostatic Artery Embolization United States Market 2020 and Forecast 2021-2027
- TBI843184
- November 25, 2020
- United States of America
- 144 pages
- SAC Insights
PAE is a non-surgical way of treating an enlarged and troublesome prostate by blocking off the arteries that feed the gland and making it shrink. It is performed by an interventional radiologist, rather than a surgeon, and is an alternative to a TURP (trans urethral resection of prostate) operation. PAE was first performed in 2009, and since then over 200 men have had the procedure performed predominantly in Portugal and Brazil. University Hospital Southampton has been offering a PAE service from April 2012 and is the first UK centre to perform this procedure.
Market Analysis and Insights: United States Prostatic Artery Embolization Market
This report focuses on United States Prostatic Artery Embolization market.
The United States Prostatic Artery Embolization market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
United States Prostatic Artery Embolization Scope and Market Size
Prostatic Artery Embolization market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Prostatic Artery Embolization market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Prostatic Artery Embolization market is segmented into
- Type 1
- Type 2
Segment by Application, the Prostatic Artery Embolization market is segmented into
- Yonger than 60
- 60-85
- Older than 85
Regional and Country-level Analysis
The Prostatic Artery Embolization market is analysed and market size information is provided by business regions.The key regions covered in the Prostatic Artery Embolization market are New England, Mideast, Great Lakes, Plains, Southeast, Southwest, Rocky Mountain, and Far West.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prostatic Artery Embolization Market Share Analysis
Prostatic Artery Embolization market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prostatic Artery Embolization business, the date to enter into the Prostatic Artery Embolization market, Prostatic Artery Embolization product introduction, recent developments, etc.
The major vendors covered:
- UNC Health Care
- Tampa General Hospital
- Henry Ford
- Spire Healthcare
This research comprehensively answers the following 9 important questions:
- Q.1. What are some of the most promising growth trends in the Prostatic Artery Embolization market in United States?
- Q.2.Which segments and sub-segments will grow at a faster pace and why? Which segment is nearing the peak and demand saturation?
- Q.3.Which region will witness a higher growth rate and why? Which region might see a slower or negative growth?
- Q.4.What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Prostatic Artery Embolization market?
- Q.5.What are the business risks and who pose challenges to the global leaders and are competitive threats in this Prostatic Artery Embolization market?
- Q.6.What are the emerging trends post COVID-19 reshuffle in this Prostatic Artery Embolization market and the what are reasons behind these trends and do they translate in global exploration?
- Q.7. Who are the major global and american regional players in the Prostatic Artery Embolization market? Which are the strategic initiatives key players are pursuing for business growth?
- Q.8.Which are the competing products in Prostatic Artery Embolization american market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.9.What M & A activity has occurred in the last 5 years and what is its impact on the Prostatic Artery Embolization industry?
Table of Contents Chapter 1. Preface 1.1. Report Description 1.1.1. Objective 1.1.2. Target Audience 1.1.3. Unique Selling Proposition (USP) & Offerings 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology 1.3.3. Level 1: Primary Research 1.3.4. Level 2: Secondary Research and Purchased Database(Statista, FactSet, Bloomberg, SDC Platinum) 1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope Chapter 2. Executive Summary 2.1. United States Prostatic Artery Embolization 2019-2029 (USD Billion) 2.2. United States Prostatic Artery Embolization: Market Snapshot Chapter 3. United States Prostatic Artery Embolization - Industry Analysis | read more...
Related Reports
